IP Library Granted Patent US 8,940,687
Granted Patent B2
US 8,940,687 · App. 13/861,236 · Granted Jan 27, 2015

Antimicrobial angiogenin complexes (ANGex) and uses thereof

Inventors: A. Satyanarayan Naidu (Diamond Bar, CA); A. G. Tezus Naidu (Santa Ana, CA); A. G. Sreus Naidu (Santa Ana, CA)
Assignee: Naidu LP
A61K38/54C07K14/515A61K39/3955G01N33/6854
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,687
App. No.
13/861,236
Granted
Jan 27, 2015
Kind
B2
Abstract

Antimicrobial compositions based upon stabilized angiogenin compositions also contain osteopontin and antimicrobial proteins such as lactoperoxidase (LPO), myeloperoxidase (MPO), salivary peroxidase (SPO) and lysozyme.

Claims (13)

1. An antimicrobial composition comprising osteopontin, an isolated angiogenin non-covalently complexed to lactoferrin and at least one antimicrobial protein selected from the group consisting of myeloperoxidase (MPO), salivary peroxidase (SPO) and lysozyme.

2. The antimicrobial composition of claim 1 , wherein the angiogenin is isolated from a biological fluid.

3. The antimicrobial composition of claim 2 , wherein the biological fluid is selected from the group consisting of colostrum, milk, whey, milk serum, blood, plasma and serum.

4. The antimicrobial composition of claim 2 , wherein the biological fluid is obtained from a mammal and wherein the mammal is selected from the group consisting of cows, buffalos, horses, sheep, pigs and camels.

5. The antimicrobial composition of claim 4 , wherein the mammal is genetically modified.

6. The antimicrobial composition of claim 1 , further comprising native angiogenin.

7. The antimicrobial composition of claim 6 , wherein the composition comprises complexed angiogenin and native angiogenin at a ratio of 1:1 to 1:10.

8. The antimicrobial composition of claim 6 , which further comprises a buffer system, a physiological acceptable base and a salt.

9. The antimicrobial composition of claim 8 , wherein the buffer system is selected from the group consisting of oxalic acid, ethylenediamine tetraacetic acid and citric acid.

10. The antimicrobial composition of claim 8 , wherein the physiological acceptable base is sodium bicarbonate.

11. The antimicrobial composition of claim 8 , wherein the salt is selected from the group consisting of sodium chloride, potassium chloride and calcium chloride.

12. A method of inhibiting microbial growth comprising administering the composition of claim 1 to a subject in need thereof.

13. The method of claim 12 , wherein the microbe is selected from the group consisting of Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Klebsiella pneumonia, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes , and Candida albicans.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 9, 2015
From: NAIDU LP
To: NAIDU LP
Reel/Frame 035866/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2014
From: NAIDU, A. SATYANARAYAN
To: NAIDU LP
Reel/Frame 033833/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2014
From: NAIDU, A. G. TEZUS; NAIDU, A. G. SREUS
To: NAIDU LP
Reel/Frame 033833/0392 →
Continuity (4)
Continuation 13185115 · Jul 18, 2011
Division 12554602 · Sep 4, 2009
Division 11734729 · Apr 12, 2007
Related Publication 20130287754A1 · Oct 31, 2013